EIK1005 drug page Clinical trials

Trials with EIK1005

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
3Countries
160Planned patients

Showing 1–1 of 1

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Recruiting Phase 1 160 patients NCT07262619

The goal of this clinical trial is to determine the most effective dose of EIK1005 that a person can take safely. Additionally, this study will test how well EIK1005 is tolerated alone and in combination with pembrolizumab in treating pati…

United States, Australia, New Zealand Jan 2026 – Mar 2029 Interventional
Combined with: Pembrolizumab

Where the recruiting trials are